Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-059324
Filing Date
2025-03-20
Accepted
2025-03-20 16:48:36
Documents
5
Effectiveness Date
2025-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 d856075ds8.htm S-8 45313
2 EX-5.1 d856075dex51.htm EX-5.1 8451
3 EX-23.2 d856075dex232.htm EX-23.2 1590
4 EX-FILING FEES d856075dexfilingfees.htm EX-FILING FEES 17041
5 GRAPHIC g856075g0317230655268.jpg GRAPHIC 2413
  Complete submission text file 0001193125-25-059324.txt   76967
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285971 | Film No.: 25757158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)